PALVELLA THERAPEUTICS, INC. ($PVLA)
Filing Information
| Accession Number | 0001104659-26-084620 |
|---|---|
| Form Type | 4 |
| Filing Date | Jul 17, 2026 |
| Document | View SEC Filing |
Transactions
8
Total Shares
12,906
Total Value
$677,074.89
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Chief Operating Officer | Common Stock | โ | Jul 15, 2026 | Exercise/Conversion | 2,154 | $7.14 | $15,379.56 | 2,154 | Direct | โ | View Details | |
Chief Operating Officer | Common Stock | โ | Jul 15, 2026 | Exercise/Conversion | 2,148 | $9.08 | $19,503.84 | 4,302 | Direct | โ | View Details | |
Chief Operating Officer | Common Stock | โ | Jul 15, 2026 | Sale | 522 | $147.14 | $76,805.25 | 3,780 | Direct | โ | View Details | |
Chief Operating Officer | Common Stock | โ | Jul 15, 2026 | Sale | 840 | $148.40 | $124,657.51 | 2,940 | Direct | โ | View Details | |
Chief Operating Officer | Common Stock | โ | Jul 15, 2026 | Sale | 1,029 | $149.27 | $153,595.43 | 1,911 | Direct | โ | View Details | |
Chief Operating Officer | Common Stock | โ | Jul 15, 2026 | Sale | 1,911 | $150.25 | $287,133.29 | 0 | Direct | โ | View Details | |
Chief Operating Officer | Stock Option (Right to Buy) | Derivative | Jul 15, 2026 | Exercise/Conversion | 2,154 | $0.00 | $0.00 | 6,473 | Direct | โ | View Details | |
Chief Operating Officer | Stock Option (Right to Buy) | Derivative | Jul 15, 2026 | Exercise/Conversion | 2,148 | $0.00 | $0.00 | 6,444 | Direct | โ | View Details |